Compare MMA & HIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | MMA | HIND |
|---|---|---|
| Founded | 2013 | 2017 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.2M | 12.9M |
| IPO Year | 2023 | 2016 |
| Metric | MMA | HIND |
|---|---|---|
| Price | $0.43 | $2.16 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | ★ 333.0K | 31.4K |
| Earning Date | 05-20-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.35 | $1.75 |
| 52 Week High | $2.88 | $12.87 |
| Indicator | MMA | HIND |
|---|---|---|
| Relative Strength Index (RSI) | 40.25 | 42.17 |
| Support Level | $0.35 | $2.02 |
| Resistance Level | $0.50 | $2.93 |
| Average True Range (ATR) | 0.06 | 0.14 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 36.40 | 49.35 |
Mixed Martial Arts Group Ltd is a technology company operating in the martial arts and combat sports industry. The company operate four core business units: i) TrainAlta: A platform that transforms MMA fans into active participants through structured training programs like the Warrior Training Program, ii) BJJLink: A gym management platform designed for BJJ academies, offering tools for payment processing, marketing, student engagement, and content monetization, iii) Hype: A marketing platform helping gym owners, coaches, and athletes grow revenue from their audiences, iv) MixedMartialArts.com: The go-to resource for MMA news, fighter data, fight schedules, and the legendary Underground forum. Its majority of revenue is in the form of Program revenue, which consists of the license fees.
Vyome Holdings Inc is a reseach and development company. The Company operates in two segments, biotechnology and pharmaceutical products. The biotechnology segment comprises of operations around VT-1953, VT-1908, and VB-1953 programs that are in development, and the pharmaceutical segment comprises of antifungal products manufacturing and distribution.